Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease (Q44531215)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease |
scientific article published in August 2003 |
Statements
1 reference
Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease (English)
1 reference
Susan H Fox
1 reference
Jonathan M Brotchie
1 reference
Juha-Matti Savola
1 reference
Michael Hill
1 reference
Mia Engstrom
1 reference
Hannele Merivuori
1 reference
Siegfried Wurster
1 reference
Steven G McGuire
1 reference
Alan R Crossman
1 reference
1 August 2003
1 reference
1 reference
18
1 reference
8
1 reference
872-883
1 reference
Identifiers
1 reference
1 reference